The conference is intended to provide a platform for exchange and networking and to foster interaction between the One NCT, DKTK, and other networks. We expect highlight talks on precision oncology activities, including recent developments in multiomics data analysis (e.g., by artificial intelligence) as well as forward and reverse translation, underlining the central role of multidimensional tumor characterization as fuel for innovative clinical trials and scientific discovery in Germany and beyond.
Date: November 5-6, 2026
Site: Heidelberg Congress Center, Czernyring 20, 69115 Heidelberg
On December 3–4, 2026, the NCT Community Retreat will bring together key stakeholders from Germany’s cancer research community at the Heidelberg Congress Center (HCC) in Heidelberg.
The retreat has established itself as an important platform for cross-site exchange, bringing together clinicians, researchers, early-career scientists, and patient representatives from the NCT, DKFZ, DKTK, and the CCC network. Participants will have the opportunity to further develop innovative study concepts for the NCT Investigator-Initiated Trial (IIT) portfolio, initiate new collaborations, and discuss emerging scientific ideas and perspectives.
